With medical science skyrocketing, developing ways to predict the fertility phase of a woman shouldn’t seem surprising. Researchers from University of Andrews Edinburgh and Glasgow have disclosed the normal levels of hormone anti-Mullerian Hormone (AMH) which seem to present the activity of the ovaries throughout a lifespan.
These revelations may help younger women gauge when they are likely to encounter menopause and their fertility span. Presently there is no trial to affirm how many immature eggs exist in a woman individually. Many professionals are known to use the AMH measurement as a substitute measure for ovarian reserve.
The team was already aware that when AMH level drops below a specific benchmark, IVF treatment ought to be less effective. As a part of the study, 3,200 specimens from healthy girls and women were taken to gauge the median levels of AMH. This will aid fertility experts to compare the woman’s AMH level to the average for her age-group.
Tom Kelsey, a lecturer in the School of Computer Science at St Andrews expressed, “We knew that high AMH levels were good for conception but we could not back that up statistically. This study now provides us the level you would expect to find in a normal healthy woman. Before, we knew that once the levels of this hormone dropped below a certain level, it was hard to conceive.”
According to Professor Richard Anderson, Professor of Reproductive Medicine at the University of Edinburgh, predicting how long a woman is fertile is essential and AMH may help in doing so. The findings suggest that AMH levels in normal women change with age. According to scientists this study will also help counsel, young patients with cancer who are at a greater risk of infertility. It will help them decide the course of fertility preservation prior to their cancer therapies. According to Professor Scott Nelson of the University of Glasgow, this analysis may pave way for gauging a woman’s potential reproductive lifespan.